Trial · NCT03439072
Results by group28
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 28
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Subjects With a Positive Glucose Response | G-Pen | 76 | Participants | ||
| Number of Subjects With a Positive Glucose Response | Lilly Glucagon | 78 | Participants | ||
| Time for Positive Glucose Response | G-Pen | 12.17 | Standard Deviation 3.604 | minutes | |
| Time for Positive Glucose Response | Lilly Glucagon | 8.58 | Standard Deviation 2.026 | minutes | |
| Number of Subjects With a Positive Response for the Combination Endpoint: Positive Glucose Response/Positive Glucose Increase | G-Pen | 76 | Participants | ||
| Number of Subjects With a Positive Response for the Combination Endpoint: Positive Glucose Response/Positive Glucose Increase | Lilly Glucagon | 78 | Participants | ||
| Number of Subjects With a Positive Glucose Increase | G-Pen | 76 | Participants | ||
| Number of Subjects With a Positive Glucose Increase | Lilly Glucagon | 78 | Participants | ||
| Time for Positive Glucose Increase | G-Pen | 11.36 | Standard Deviation 3.345 | minutes | |
| Time for Positive Glucose Increase | Lilly Glucagon | 8.02 | Standard Deviation 1.856 | minutes | |
| Number of Subjects With a Positive Response for the Combination Endpoint: Positive Glucose Response/Relief of Neuroglycopenic Symptoms | G-Pen | 76 | Participants | ||
| Number of Subjects With a Positive Response for the Combination Endpoint: Positive Glucose Response/Relief of Neuroglycopenic Symptoms | Lilly Glucagon | 78 | Participants | ||
| Number of Subjects With Relief of Neuroglycopenic Symptoms | G-Pen | 74 | Participants | ||
| Number of Subjects With Relief of Neuroglycopenic Symptoms | Lilly Glucagon | 77 | Participants | ||
| Time to Resolution of Autonomic Symptoms | G-Pen | 13.8 | Standard Deviation 10.89 | minutes | |
| Time to Resolution of Autonomic Symptoms | Lilly Glucagon | 12.0 | Standard Deviation 7.44 | minutes | |
| Time to Resolution of Neuroglycopenic Symptoms | G-Pen | 14.2 | Standard Deviation 15.12 | minutes | |
| Time to Resolution of Neuroglycopenic Symptoms | Lilly Glucagon | 12.2 | Standard Deviation 8.85 | minutes | |
| Time to Resolution of the Feeling of Hypoglycemia | G-Pen | 11.6 | Standard Deviation 6.45 | minutes | |
| Time to Resolution of the Feeling of Hypoglycemia | Lilly Glucagon | 13.1 | Standard Deviation 7.86 | minutes |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03439072/results